Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development, and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
In 2021 and 2022 Incyte Dermatology launched a topical treatment for atopic dermatitis and nonsegmental vitiligo, respectively. To learn more, visit ADtreatment.com or treatvitiligotoday.com.